Active Ingredient(s): Bromfenac
FDA Approved: * March 24, 2005
Pharm Company: * ISTA PHARMS
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Xibrom Overview

Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID)[1] marketed in the US as an ophthalmic solution (brand names Prolensa and Bromday,[2] prior formulation brand name Xibrom, which has since been discontinued) by ISTA Pharmaceuticals for short-term, local use. Prolensa and Bromday are the once-daily formulation of bromfenac, while Xibrom was approved for twice-daily administration. In the European Union, the brand name is Yellox. Bromfenac is indicated f...

Read more Xibrom Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bromfenac

Recent Xibrom Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Solution: 0.07%, 0.075%, 0.09%, 0.1035%
  • Solution/drops: 0.09%, Eq 0.07% Acid, Eq 0.075% Acid, Eq 0.09% Acid
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Bromfenac or a similar ingredient: (3 results)